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A number of new studies have introduced a
different risk score in contrast to National
Institute of Health Stroke Scale (NIHSS)
to predict prognosis in ischemic stroke
(1, 2). Other recent studies have evalu-
ated NIHSS and compared traditionally
established risk scores, with newly modi-
fied models (3–8). New modeling can ease
the access of scaling systems, develop a bet-
ter educational background, and reveal the
main common basis of the more complex
models. Though the idea is clever, we’d
like to highlight three educational concerns
regarding the handling of the future stud-
ies on NIHSS, stroke scaling, and relative
comparisons.
FIRST: NIHSS vs. STROKE IMPACT
SCALE
First of all, the NIHSS was not intended as a
predictor of outcome from stroke. Rather,
it was intended to standardize the degree of
neurological deficit in acute stroke so that
treatments for acute stroke could be com-
pared based upon how severe the stroke
was. In recent years, many authors have
used the scale as a predictor but that was
not the intent and hence there are prob-
lems with it in this regard. In contrast,
other measures like the Stroke Impact Scale
(SIS) were designed for prognostic pur-
poses. We suggest using SIS, which covers
eight dimensions and a composite disabil-
ity score, for assessing the outcome in acute
stroke (9). SIS has shown to be a feasi-
ble, reliable, valid, and sensitive scale (9).
Even proxies can provide valid informa-
tion for assessing the stroke outcome by
applying SIS (10). This is a great advan-
tage, especially when using SIS for research
purposes.
SECOND: ASSESSING A SENSITIVE
METHOD AND CLAIMING THE CLINICAL
UTILITY
This is how the story goes on in many
surveys: they typically derive a scoring sys-
tem from their cohort of ischemic stroke
patients and compare it to a standard estab-
lished model like NIHSS. The compari-
son of the new model with traditional
NIHSS may reveal modest though non-
significant decrement, and the interpreta-
tion admits the applicability of the newer
method. However, when Receiver Oper-
ating Curve (ROC) is the main applied
method, we should consider further analy-
sis. Recent studies have shown that
C-statistics is not sensitive to show
discrimination of an additive model (11).
C-statistics (exp: ROC curve and corre-
sponding Area Under the Curve, AUC)
loses its ability in detecting the discrim-
inatory difference, especially with regard
to outcomes’ prevalence (12, 13). As in
most cases, when the baseline predic-
tive ability is considerable (AUC& 0.80),
incremental AUC wouldn’t go beyond
minor changes. Despite large difference in
discriminatory power of two comparing
models, AUC may show minimal decline
and thus fail to reveal the prediction supe-
riority. Applying newer methods, which are
more sensitive is the plausible manner we
should look for (14). As a simple exam-
ple, Integrated Discriminatory Improve-
ment (IDI) would be a suitable choice,
especially when the authors’ objective is to
choose a simpler method to be as pow-
erful as the traditional NIHSS by using
discriminant analysis. IDI is calculated by
comparing the discrimination slopes of
the two models (13–15). Absolute IDI’s
interpretation remains to be understood.
However, as stated by Pencina et al. rel-
ative IDI (rIDI, equaling IDI divided by
the traditional model’s slope) has an “intu-
itive” definition (15). rIDI can show the
portion of the traditional model, which
can be explained by a new method. One
can simply calculate the discrimination
slopes, their difference (IDI), and the per-
centage of improvement (or failure) from
traditional NIHSS to a new model. This
rIDI matches the percentage of the pre-
dictive prognostic value of NIHSS, which
can be explained by the variables in the
new model. In the other word, we can
explain the percentage of improvement we
gain (or lose) by summarizing the com-
plex NIHSS to a new pointing system.
This is far more applicable. Recent stud-
ies have claimed that the rIDI can assess
the “Clinical utility” (15) of the model
as well.
Comparisons with NIHSS can be more
clarified by taking the time to event (TTE)
into account. TTE is an important compo-
nent of prediction models, specifically in
case of stroke (16). TTE seems to be the
next missing point in most of such cohorts.
IDI can also be estimated using the TTE
values of the studied cases (14, 15).
We exemplify the usage of discrimi-
nant slopes, IDI, rIDI and their superiority
in comparison with C-statistics, and ROC
curve analysis, in a series of 117 consecu-
tively referred patients to our private clinic.
All patients had been finally diagnosed as
having an ischemic stroke event. Neither
of them had previous history of ischemic
events, nor was receiving treatments prior
to the event. NIHSS items and the inci-
dence of mortality were recorded. Here
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we compare two short NIHSS (sNIHSS)
scores introduced by Tirschwell et al. for
utilization in pre-hospital settings (1).
Eight of the NIHSS items were selected
as follow: right leg, left leg, gaze, visual
fields, language, level of consciousness,
facial palsy, and dysarthria. The two intro-
duced models were defined as sNIHSS-8
and sNIHSS-5, including the first eight
and the first five, of the afore-mentioned
items, respectively. In our simulation we
used binary logistic regression analysis with
mortality as the dependent variable (0 or
1) and each model’s items as the covariates.
Probabilities of the sNIHSS-8 and sNIHSS-
5 were saved and used for the comparison
of the two models. In ROC curve analysis,
the AUC was 0.943 (0.882–1.000) and 0.922
(0.816–1.000) for sNIHSS-8 and sNIHSS-
5, respectively. As you see, AUC results were
almost similar with no statistical significant
difference among the two models. Next,
we calculated the discrimination slope, IDI
and rIDI for the two models. By short-
ening the sNIHSS-8 to the sNIHSS-5, the
discrimination slope reduced from 0.62 to
0.55, IDI was reduced by −0.07 and rIDI
was calculated as ~13%. Practically, this
means that we lost up to 13% of our pre-
dictor power; while C-statistics failed to
show any decrement, which was due to
the large predictor power of the baseline
model.
As we explained and exemplified, ROC
curve analyses (and C-statistics in gen-
eral) are not sensitive to change when the
baseline model has already a large power
of prediction (14). This is what almost
always happens with validated scoring sys-
tems. To detect smaller changes in the
model, we suggested using a more sen-
sitive effect measure estimator, including
discrimination slope and IDI. By using
them, we can detect smaller changes and
come up with a more realistic estima-
tion of change. Besides, for every obtained
effect size, we can increase our preci-
sion by using techniques that provide us
with a more definitive result; like hav-
ing narrower confidence intervals for test-
ing a hypothesis. In ROC curve analy-
ses, obtaining a precise standard error will
become critical when especially binormal
assumptions about the latent frequency
distributions of test results are not met
(17). Re-sampling methods can aid us in
attaching a distribution-independent stan-
dard error, to a point estimate. Jackknife
[by Tukey (18)] and bootstrapping [by
Efron (19)] are the two most famous
re-sampling methods (20). They act as
companions to a sensitive effect size. In fact,
Jackknife and bootstrapping are measures
of precision, whereas, sensitive effect esti-
mators are measures of accuracy. While the
former deals with reproducibility, the latter
deals with reality.
THIRD: DERIVATION vs. VALIDATION
COHORT
When authors derive a scoring system from
their cohort of stroke patient, statistical
analysis results in the best fitted predictive
model using the new method’s variables in
their cohort. The cohort which gives born
to the model is so called as the “Derivation”
or “Construction” cohort. Similar to sev-
eral previous models in different fields of
medicine (21), and specifically in predict-
ing cardiovascular events (22), one would
expect the model to be tested, compared
or so called as “Validated” in a different,
separate, and independent cohort. The pre-
dictive ability of the new model in the
sample it has been derived from (and thus
fits by definition) is not indicative. Fur-
ther evaluations on different samples are
always needed to admit the validity of a
new model.
Finally, we conclude that using a val-
idation cohort accompanied by acquir-
ing more sensitive measures can reveal
the predictive value of the short scor-
ing systems and newer methods in com-
parison to NIHSS or other established
scales.
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